Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00673842 · ClinicalTrials.gov registry record · Phase 3
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
A Phase 3 study of Myocardial Infarction and Sudden Death, sponsored by University of Calgary.
- Completed
- Registry status
- Phase 3
- Development phase
- 700
- Enrollment target
- 20
- Study locations
NCT00673842: Completed Phase 3 study of Myocardial Infarction and Sudden Death, sponsored by University of Calgary.
NCT00673842 is a Phase 3 study of Myocardial Infarction and Sudden Death that has completed, run by University of Calgary. The registered enrollment target is 700 participants, below the 4,671-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (85% lower). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00673842, a Phase 3 study of Myocardial Infarction and Sudden Death, has completed, sponsored by University of Calgary.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 700 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study will assess whether an implantable defibrillator will increase the likelihood of survival in patients who have had a heart attack, have abnormal test results from a 24 hour heart monitor, and who have low normal heart function.
Conditions Studied
Interventions
- OTHER Usual care
- DEVICE Implantable Cardioverter Defibrillator + Usual Care
Study Locations (20)
Ohio
- Northeast Ohio Cardiovascular Specialists - Akron
- The Lindner Research Center - Cincinnati
- Bethesda North Hospital - Cincinnati
- Cleveland Clinic - Cleveland
- The Ohio State University - Columbus
Michigan
- Washington University Medical School - Saint Louis
- St. John Providence Hospital - Southfield
New Jersey
- The Valley Hospital - Ridgewood
- Associated Cardiovascular Consultants/Lourdes Cardiology Services - Voorhees Township
New York
- North Shore LIJ - New York
- New York Presbyterian Hospital - New York
Alabama
- Heart Center Research LLC - Huntsville
Colorado
- Colorado Heart and Vascular - Lakewood
Florida
- James A Haley Veterans' Center - Tampa
Indiana
- The Heart Group/Deaconess - Evansville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2011-04-18 |
| Est. Completion | 2024-10-31 |
| Phase | Phase 3 |
What the finished NCT00673842 record still lists
NCT00673842 is an interventional study that assigns participants to a tested intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, below the 4,671-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Myocardial Infarction appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.
NCT00673842 names 20 study sites across 13 states, led by Ohio, Michigan, New Jersey.
Frequently Asked Questions
What is clinical trial NCT00673842 about?
NCT00673842 is a clinical study titled "Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction". This study will assess whether an implantable defibrillator will increase the likelihood of survival in patients who have had a heart attack, have abnormal test results from a 24 hour heart monitor, and who have low normal heart function.
What is the current status of trial NCT00673842?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 700 participants. The study started on 2011-04-18. Estimated completion is 2024-10-31.
What conditions does trial NCT00673842 study?
This clinical trial studies the following conditions: Myocardial Infarction, Sudden Death.
What interventions are being tested in trial NCT00673842?
The interventions under investigation include: Usual care (OTHER), Implantable Cardioverter Defibrillator + Usual Care (DEVICE).
Who is sponsoring clinical trial NCT00673842?
This trial is sponsored by University of Calgary, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00673842 being conducted?
This trial has 20 study locations across Alabama, Colorado, Florida, Indiana, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00673842's enrollment target sits among peer trials
700 22nd of 64 higher than 43 of 64 other Myocardial Infarction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myocardial Infarction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging
COMPLETED · Phase 3
-
Occluded Artery Trial (OAT)
COMPLETED · Phase 3
-
IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.
COMPLETED · Phase 3
-
An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
COMPLETED · Phase 3
-
Myocardial Ischemia and Transfusion Pilot
COMPLETED · Phase 3
-
Vitamin Therapy for Prevention of Stroke
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI